SLC6A4 and atherosclerosis: In our study, we found that mice with impaired cholesterol metabolism and developing atherosclerosis have an increased expression of mAbs against SERT, 5HT2A, and 5HT2B compared to control-group animals, which was consistent with other in vitro and in vivo studies [45].